圣湘生物：2025年度业绩快报公告

Group 1 - The core viewpoint of the article is that Shengxiang Bio announced its financial performance for 2025, projecting a total operating revenue of 1.648 billion yuan, which represents a year-on-year growth of 13.04% [2] - The net profit attributable to shareholders of the listed company is expected to be 198 million yuan [2]